CRIS Current Research Information System

SEMPRINI, MARIA SOFIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.011
EU - Europa 574
NA - Nord America 453
Continente sconosciuto - Info sul continente non disponibili 72
AF - Africa 44
SA - Sud America 31
OC - Oceania 1
Totale 2.186
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 431
IT - Italia 342
CN - Cina 320
VN - Vietnam 237
SG - Singapore 218
KR - Corea 78
NL - Olanda 61
HK - Hong Kong 53
DE - Germania 41
IN - India 26
FI - Finlandia 23
FR - Francia 23
BD - Bangladesh 22
BR - Brasile 21
JP - Giappone 20
CI - Costa d'Avorio 16
GB - Regno Unito 13
AT - Austria 11
CA - Canada 10
ZA - Sudafrica 10
CH - Svizzera 9
IE - Irlanda 7
RU - Federazione Russa 7
SC - Seychelles 7
IQ - Iraq 6
MX - Messico 6
UA - Ucraina 6
AR - Argentina 5
TH - Thailandia 5
DK - Danimarca 4
LT - Lituania 4
PH - Filippine 4
SE - Svezia 4
TW - Taiwan 4
DZ - Algeria 3
ES - Italia 3
MY - Malesia 3
GE - Georgia 2
ID - Indonesia 2
IR - Iran 2
JM - Giamaica 2
LI - Liechtenstein 2
MA - Marocco 2
PK - Pakistan 2
PL - Polonia 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BJ - Benin 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
GI - Gibilterra 1
GM - Gambi 1
GP - Guadalupe 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MN - Mongolia 1
MU - Mauritius 1
PY - Paraguay 1
RS - Serbia 1
TG - Togo 1
TN - Tunisia 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 2.114
Salva come PNG Salva come JPEG
Città #
Hefei 168
Singapore 165
Bologna 107
Seoul 76
Ho Chi Minh City 73
San Jose 58
Hanoi 57
Ashburn 52
Hong Kong 49
Milan 43
Council Bluffs 40
Dallas 30
Los Angeles 23
New York 23
Boardman 19
Beijing 18
Abidjan 16
Casalecchio di Reno 16
Bengaluru 14
Santa Clara 13
Tokyo 13
Lauterbourg 11
Helsinki 10
Houston 10
Johannesburg 9
Lappeenranta 9
Rimini 9
Vienna 9
Da Nang 8
Haiphong 8
Amsterdam 7
Bern 7
Chicago 7
Dublin 7
Frankfurt am Main 7
Vicenza 7
Falkenstein 6
Kyiv 6
Munich 6
Parma 6
São Paulo 6
Tongling 6
Biên Hòa 5
Bo 5
Cimitile 5
Turin 5
Bremen 4
Galliera 4
Guangzhou 4
Modena 4
Rome 4
San Francisco 4
Shanghai 4
Turku 4
Wangen 4
Algiers 3
Baghdad 3
Bangkok 3
Bergamo 3
Berlin 3
Boydton 3
Buffalo 3
Bắc Giang 3
Bến Tre 3
Can Tho 3
Ceuti 3
Ha Long 3
Hải Dương 3
Naples 3
Orem 3
Qingdao 3
Redondo Beach 3
Thái Nguyên 3
Vanløse 3
Visakhapatnam 3
Bari 2
Barnet 2
Bexley 2
Boston 2
Bratislava 2
Buenos Aires 2
Castenaso 2
Cento 2
Chandler 2
Colmar 2
Dalian 2
Denver 2
Dhaka 2
Formigine 2
Freiburg im Breisgau 2
Hamburg 2
Hyderabad 2
Jacksonville 2
Kuala Lumpur 2
Liverpool 2
London 2
Long Xuyen 2
Lucca 2
Lấp Vò 2
Marion 2
Totale 1.400
Salva come PNG Salva come JPEG
Nome #
PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD) 234
Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma 217
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC 216
Functional evaluation of circulating anti-cancer antibodies with a 3D tumor cell growth inhibition assay 215
Cancer vaccines: Target antigens, vaccine platforms and preclinical models 212
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations 211
Lipid rafts, caveolae, and epidermal growth factor receptor family: friends or foes? 202
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy 190
Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine 182
Preclinical activity of ES2B-C001, a human candidate HER-2 virus-like particle (VLP) vaccine, against mammary carcinoma onset and metastasis 147
Development of cellular models expressing cynomolgus (Macaca fascicularis) HER2 for the functional evaluation of cross-reactive anti-human HER2 response 84
Alternatives for fetal bovine serum (FBS) and sustainability of milk derivatives in cell culture 33
Requalified bovine milk as a sustainable supplement for cell cultures 26
HER-2 therapeutic vaccine is not hampered by concurrent HER-2 monoclonal antibody 17
Totale 2.186
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.131
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.131
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202376 0 0 0 7 13 12 10 2 9 2 8 13
2023/202487 5 1 21 11 16 9 6 7 0 6 1 4
2024/2025534 6 22 13 14 44 29 72 44 14 80 66 130
2025/20261.414 128 270 123 134 78 57 109 35 211 92 83 94
2026/202775 44 31 0 0 0 0 0 0 0 0 0 0
Totale 2.186